Type: Subsidiary
On the web: http://www.appdrugs.com

Your eyes are getting heavy. You're getting sleepy. No hypnotist here, just APP Pharmaceuticals, a company that develops, makes, and markets anesthetics and other injectable drugs. Specializing in generics, APP's critical care segment includes market-leading general anesthetic Diprivan and blood thinner heparin. Other product segments focus on injectable oncology treatments and drugs that fight ear, heart, respiratory tract, skin, and sinus infections. APP markets through a direct sales force and often sells through group purchasing organizations to customers that include hospitals, long-term care facilities, and clinics in North America. The company is a subsidiary of German medical firm Fresenius.

Officers:
President and CEO: John Ducker
EVP and COO: Frank Harmon
EVP and CFO: Richard J. Tajak

Competitors:
Baxter International
Hospira
Teva Pharmaceuticals USA

© 2012 Hoover's, Inc. All rights reserved.